Blog | Veristat Insights

Join Veristat To Support Rare Cancer Research

January 10, 2018

CYCLE FOR SURVIVAL 2018

Every dollar represents hope, strength, and a lasting impact!

Read More

Delivering Smarter, Faster & Patient-Centric  Clinical Trials with Integrated Clinical Technologies

November 17, 2017

A Recap of the New York Medidata NEXT Event: Where Science Meets Technology Meets the Future

 

Kathleen Boruchowski, Associate Director of Data Management, attended the Medidata NEXTconference in New York City on November 8-10. The conference, which has many global locations throughout the year, offered Medidata’s customers a front row seat to learn how data, insights, and technology are transforming the clinical trials industry and ultimately accelerating the hope for patients desperately seeking new treatment options.

Read More

Clinical Development Is A Team Sport

November 8, 2017

Veristat Hosts Its 2017 Annual International Company Meeting

Last week, Veristat gathered nearly 200 team members from multiple countries for our annual International Company Meeting.    What better a place to host our team meeting than Gillette Stadium, home to the five-time Superbowl championship winning New England Patriots.  

Read More

Fight Or Flight:  Reflections on Veristat's Light The Night Experience

October 27, 2017

If you heard the phrase, “You have cancer,” what would be your response?

Read More

What Drives Clinical Trial Quality Today?

October 18, 2017

Explore What We Learned at the 8th Clinical Quality Oversight Forum 

Veristat’s Senior Director of Corporate Compliance attended the 8th Clinical Quality Oversight Forum, an annual conference which took place 10-13 October 2017 in Philadelphia, PA.   

Read More

Celebrating The Success of Velcade | 14 Years Later

August 3, 2017

Last week, Veristat attended the Massachusetts Biotechnology Council (MassBio) forum titled “Evolution of an Academic Discovery: First Person Account of the Development of Velcade®”.   

Read More

How Do You Make Informed Decisions about Implementing Adaptive Designs?

December 15, 2016

Read more about this and the discussions that you missed at the MassBio Forum on Adaptive Designs in Clinical Research that took place last month.

Read More

Veristat Pauses to Celebrate its Dedication to Making Lives Longer and Healthier

November 23, 2016

Just last week, in the midst of the daily chaos of building new clinical trial databases, working on impending regulatory submissions, holding project team meetings, and programing tables figures & listings, Veristat paused its operations for one day in order to reflect upon and celebrate its contributions to drug development.

Read More

How to Select & Execute a Biomarker-Driven Clinical Trial Designs

October 4, 2016

At the 2016 Duke Industry Statistics Symposium, Dr. Robin Bliss, in collaboration with Dr. Jing Wang of Gilead Sciences, lead a discussion on “Biomarker-Driven Clinical Trial Designs for Precision Medicine.”  Dr. Bliss highlighted two Adaptive Enrichment Clinical Trials performed by Veristat as case studies for how to select and execute an enrichment clinical trial design.

Read More